New drug shows promise for debilitating sickle cell complication
NCT ID NCT03938454
Summary
This study tested whether a drug called crizanlizumab could reduce the frequency of painful, prolonged erections (priapism) in men with sickle cell disease. 36 male participants aged 12 and older, who had experienced several priapism events, received the drug via intravenous infusion for one year. The main goal was to see if the treatment safely lowered the number of these distressing episodes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIAPISM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Brody School of Medicine
Greenville, North Carolina, 27834, United States
-
Childrens Hosp Boston Dept of Hematology
Boston, Massachusetts, 02115, United States
-
Childrens National Hospital
Washington D.C., District of Columbia, 20010, United States
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Emory University School of Medicine
Atlanta, Georgia, 30303, United States
-
Foundation for Sickle Cell Disease Research
Hollywood, Florida, 33021, United States
-
LSU Medical Center
Shreveport, Louisiana, 71130, United States
-
Montefiore Medical Center
The Bronx, New York, 10461, United States
-
Prisma Health Upstate
Greenville, South Carolina, 29615, United States
-
University Of Alabama
Birmingham, Alabama, 35294, United States
-
University of Connecticut Health Center
Farmington, Connecticut, 06030, United States
-
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213-2548, United States
-
University of Texas Medical School
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.